Some hoped FDA approval of Pfizer's COVID vaccine would convince unvaccinated Americans. It didn't, study finds.

6 April 2022 - After the Food and Drug Administration approved Pfizer-BioNTech’s COVID-19 vaccine in August, public health experts were ...

Read more →

Medscape awarded contract from FDA to develop educational programming focused on biosimilars

14 February 2022 - Medscape Education has been awarded a contract from the U.S. FDA for the development of an ...

Read more →

Full FDA approval is needed to overcome vaccine hesitancy

26 July 2021 - As the Delta variant spreads, what is the agency waiting for? ...

Read more →

Factors associated with generic drug uptake in the United States, 2012 to 2017

19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...

Read more →

Social media disinformation campaigns tied to vaccine hesitancy

29 October 2020 - Social media disinformation campaigns designed to cast doubt on the safety and effectiveness of vaccines are contributing ...

Read more →

Prescriptions surged as Trump praised drugs in coronavirus fight

25 April 2020 - Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on ...

Read more →

Draft Pelosi plan targets drugs lacking biosimilar or generic option

12 September 2019 - While chances of her leaked plan to force lower drug prices in the United States getting through ...

Read more →

We need to make biosimilars easier to get

11 September 2019 - If potential biosimilar manufacturers can’t get their product to market, they won’t proceed with development. ...

Read more →

Biosimilars Forum’s public letter in response to anti-biosimilars Op-Ed

29 August 2019 - Government Should Not “Throw In the Towel on Biosimilars,” They Should Act Now to Unlock Billions ...

Read more →

We need a more rational biosimilars policy

27 August 2019 - Throwing in the towel on a whole new category of medicines, just shy of a decade in, ...

Read more →

Don’t give up on biosimilars—Congress can give them a boost

25 August 2019 - Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process. ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

Biosimilars continue to exhibit market failure

11 July 2019 - From their inception, biosimilars in the U.S. have faced headwinds.  ...

Read more →

How big pharma suppresses ‘biosimilars’

23 June 2019 - Deals with insurers and pharmacy benefit managers at patient and taxpayer expense. ...

Read more →

Biopharma CEOs explain problems with biosimilars to Congress

12 April 2019 - Following their Senate Finance Committee hearing in February, all seven biopharmaceutical CEOs have now offered hundreds ...

Read more →